Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
SkinnyRx at a Glance
- What it is
- A large, well-reviewed operation that received an FDA warning letter in February 2026 over false or misleading claims
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide (injection)
- Compounded tirzepatide (injection)
- Pricing
- Compounded semaglutide from about $199/mo and tirzepatide from about $299/mo — no insurance required
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is SkinnyRx?
SkinnyRx, operated by Lean Rx, Inc. and based in Sacramento, California, is one of the larger compounded GLP-1 telehealth operations. It is LegitScript-certified, works with licensed US physicians and state-licensed pharmacies, and holds an unusually strong public review score — over 4,100 Trustpilot reviews averaging 4.8 out of 5. On the surface that is a good record.
One matter of public record sits against it, and we think it belongs at the top rather than buried in a footnote. On 20 February 2026 the FDA issued Lean Rx, Inc., trading as SkinnyRx, a warning letter (reference 717989). Having reviewed skinnyrx.com in December 2025, the FDA concluded that false or misleading claims on the website concerning its compounded semaglutide and tirzepatide products violated sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act — the provisions under which a drug is misbranded if its labelling is false or misleading in any particular.
That letter was part of an enforcement sweep covering 30 telehealth companies over compounded GLP-1 marketing. It concerns how the products were advertised rather than a finding about the medication itself, and it does not mean the company is fraudulent. It does mean a federal regulator examined this company's claims and found them misleading, which is worth weighing against a 4.8-star review average.
On price, SkinnyRx is mid-market: roughly $199/month for compounded semaglutide and $299/month for compounded tirzepatide, with no insurance involved. Against Ondra Health at $96 or Trimi at $99, that is not competitive on cost alone.
How the Program Works
- Consultation process
- Online intake reviewed by licensed US physicians, with prescribing where clinically appropriate. No insurance is required or accepted.
- Eligibility
- Clinician-assessed at intake. SkinnyRx does not publish a BMI threshold or a list of states it serves.
- Provider involvement
- Licensed US physicians prescribe and manage treatment, with medication dispensed by state-licensed pharmacies. SkinnyRx does not name a medical director.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Compounded medication from state-licensed US pharmacies. SkinnyRx does not name them.
- Shipping frequency
- Monthly shipments. Fast shipping is one of the themes in its positive reviews.
- Support services
- Clinician-guided care with ongoing support. Communication delays and billing or cancellation timing appear in its complaint record.
SkinnyRx Pricing
- Membership fee
- None published separately. The medication price is presented as covering the programme.
- Medication fee
- Reported at approximately $199/month for compounded semaglutide and approximately $299/month for compounded tirzepatide.
- Cancellation policy
- Not published in detail. Cancellation timing relative to the next shipment is among the most common complaints, so confirm your billing date and the notice required in writing before subscribing.
- Refund policy
- Not published. Compounded medication is not returnable once dispensed.
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- HSA / FSA
- Not published. Confirm with your plan administrator.
Pricing details worth knowing
- This is mid-market pricing. Ondra Health publishes $96/month and Trimi $99/month annually for compounded semaglutide, and NovoCare sells FDA-approved Wegovy at $149/month.
- Cancellation timing is a recurring theme in complaints — customers describing confusion about when to cancel to avoid being charged for the next shipment. Establish your billing date and the cancellation deadline at signup.
- The gap between its Trustpilot score (4.8 across 4,100-plus reviews) and its BBB standing (B rating, not accredited, with 145 complaints on file) is wide. Read the complaint themes rather than either average.
- Some complaints reflect expectations rather than company failures — people expecting faster results, or not realising GLP-1 doses titrate up over weeks to months. That is a reason to read complaint detail rather than counts.
Prices change. Every figure above was taken from SkinnyRx's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- LegitScript certified, working with licensed US physicians and state-licensed pharmacies
- One of the strongest public review scores here — around 4.8 out of 5 across more than 4,100 Trustpilot reviews
- Fast shipping is a consistent theme in positive feedback
- No separate membership fee on top of the medication price
- A large operation with a substantial customer base rather than a company formed last year
Cons
- Received an FDA warning letter on 20 February 2026 finding website claims false or misleading and the products misbranded
- Mid-market pricing — roughly twice what the cheapest compounded providers publish
- BBB rates it B and does not accredit it, with 145 complaints on file
- Cancellation timing and billing confusion recur in complaints
- Does not name its compounding pharmacies, a medical director, or the states it serves
- Compounded only, with no brand-name or FDA-approved pathway
Who SkinnyRx May Be Best For
Honestly, few readers while the regulatory record stands — there are cheaper providers with cleaner records
Anyone who has read the FDA warning letter and judges that the marketing findings do not affect the care they would receive
Limitations
Read the FDA warning letter before deciding. It is public and short — search the FDA warning letter database for "Lean Rx" or reference 717989.
Diary your cancellation deadline. Being charged for a shipment you meant to cancel is the single most common complaint pattern here.
You are paying roughly double the cheapest compounded rates for a product in the same regulatory category.
Compounded medication carries the caveats described below, including the FDA proposal published in May 2026.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to SkinnyRx — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to SkinnyRx
Ondra Health
Half the price at $96/mo, names all five of its compounding pharmacies, and has no comparable regulatory record
Read review →Trimi
$99/mo with named pharmacies, a licence number and a published medical director
Read review →NovoCare Pharmacy
FDA-approved Wegovy at $149/mo — no compounding, no misbranding questions
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats SkinnyRx for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
Did SkinnyRx receive an FDA warning letter?
Yes. The FDA issued Lean Rx, Inc., trading as SkinnyRx, a warning letter dated 20 February 2026, reference 717989. Having reviewed skinnyrx.com in December 2025, the FDA determined that false or misleading claims on the website concerning its compounded semaglutide and tirzepatide products violated sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, under which a drug is misbranded if its labelling is false or misleading in any particular. SkinnyRx was one of 30 telehealth companies to receive letters in that enforcement action. You can read it on the FDA warning letter database.
Is SkinnyRx legitimate?
It is a real, substantial operation — LegitScript-certified, working with licensed US physicians and state-licensed pharmacies, with more than 4,100 Trustpilot reviews averaging around 4.8 out of 5. It is not a fake pharmacy. The concern is narrower and specific: a federal regulator reviewed its website in December 2025 and found its claims about its compounded products false or misleading. That is a finding about marketing rather than about the medication, but it is a finding.
How much does SkinnyRx cost?
Reported pricing is approximately $199/month for compounded semaglutide and approximately $299/month for compounded tirzepatide, with no separate membership fee and no insurance involved. That places it in the middle of this market — roughly double what Ondra Health ($96/month) and Trimi ($99/month annually) publish, and above NovoCare's $149/month for FDA-approved Wegovy.
Why do SkinnyRx reviews look so good on Trustpilot but worse on BBB?
The platforms attract different populations and measure different things. Trustpilot collects reviews broadly, including solicited ones from satisfied customers, and SkinnyRx scores around 4.8 across more than 4,100 of them. The BBB rates it B without accreditation and holds 145 complaints. Read the themes rather than the averages: billing, cancellation timing and communication delays recur, while some complaints reflect expectations about how quickly GLP-1 doses titrate rather than company failures.
Is SkinnyRx's compounded semaglutide FDA-approved?
No. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. In this case the FDA has gone further and specifically found the claims made about these products on the company's website to be false or misleading. Compounded semaglutide shares an active ingredient with Wegovy and Ozempic, but sharing an ingredient is not equivalence.
Who should not use SkinnyRx?
Anyone shopping on price, since cheaper providers with cleaner regulatory records exist. Anyone uncomfortable with the February 2026 warning letter. Anyone who may need a refund or a cancellation to take effect cleanly. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation during titration. A licensed clinician who knows your history should make that assessment.
The Verdict
SkinnyRx sells compounded semaglutide from around $199/month and compounded tirzepatide from around $299/month, is LegitScript-certified, and carries one of the strongest public review scores in this comparison. It also received an FDA warning letter on 20 February 2026 finding that claims on its website were false or misleading and its compounded products therefore misbranded.
Opens SkinnyRx's official site · Verify current pricing there
Compare Every Provider Side by Side
See how SkinnyRx stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from SkinnyRx's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where SkinnyRx does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- US Food and Drug Administration warning letter to Lean Rx, Inc. dba SkinnyRx, reference 717989, dated 20 February 2026 — skinnyrx.com reviewed in December 2025; FDA concluded that false or misleading claims concerning its compounded semaglutide and tirzepatide products violated sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act
- FDA press announcement on warning letters issued to 30 telehealth companies over illegal marketing of compounded GLP-1s
- Better Business Bureau profile, SkinnyRX, 2108 N St Ste N, Sacramento CA 95816 — rating B, not BBB accredited, listed under Pharmacy; third-party reporting of 145 complaints on file (checked August 7, 2026)
- Trustpilot — approximately 4.8 out of 5 across more than 4,100 reviews
- Third-party pricing reporting of approximately $199/month for compounded semaglutide and approximately $299/month for compounded tirzepatide, with LegitScript certification and licensed US physicians and state-licensed pharmacies
- Note on access: skinnyrx.com returned no readable page content to our direct requests, so pricing and programme details above are attributed to third-party reporting rather than pages we loaded ourselves (checked August 7, 2026)
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.